Cargando…

The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study

BACKGROUND: Poor adherence to antidiabetic medications leads to a higher rate of hospital admissions and adverse health outcomes in type 2 diabetes mellitus patients. OBJECTIVE: This study aims to evaluate whether a pharmacist-led medication therapy management, compared to the usual care, could enha...

Descripción completa

Detalles Bibliográficos
Autores principales: Erku, Daniel A., Ayele, Asnakew A., Mekuria, Abebe B., Belachew, Sewunet A., Hailemeskel, Bisrat, Tegegn, Henok G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597801/
https://www.ncbi.nlm.nih.gov/pubmed/28943985
http://dx.doi.org/10.18549/PharmPract.2017.03.1026
_version_ 1783263775593332736
author Erku, Daniel A.
Ayele, Asnakew A.
Mekuria, Abebe B.
Belachew, Sewunet A.
Hailemeskel, Bisrat
Tegegn, Henok G.
author_facet Erku, Daniel A.
Ayele, Asnakew A.
Mekuria, Abebe B.
Belachew, Sewunet A.
Hailemeskel, Bisrat
Tegegn, Henok G.
author_sort Erku, Daniel A.
collection PubMed
description BACKGROUND: Poor adherence to antidiabetic medications leads to a higher rate of hospital admissions and adverse health outcomes in type 2 diabetes mellitus patients. OBJECTIVE: This study aims to evaluate whether a pharmacist-led medication therapy management, compared to the usual care, could enhance medication adherence and reduce hospital admission in patients with type 2 diabetes mellitus. METHODS: A prospective randomized controlled study was conducted in patients with type 2 diabetes mellitus from February 1 to July 30, 2016. Patients in the control group (n=65) received the usual care while patients in the intervention group (n=62) received a personalized pharmacotherapeutic care plan and diabetes education. The two groups were compared by repeated measure ANOVA at 3 and 6-months with medication adherence (using Morisky medication adherence scale) and number of hospital admissions as the main outcome variables. RESULTS: A total of 127 patients were included in the study. A marked and statistically significant increase in medication adherence from baseline to 3 and 6 months were noted in the intervention group (increased from 9.2% at baseline to 61% at 6 month) compared with the control group (increased from 13.2% at baseline (to 30.2% at 6 month; p-value<0.01). Furthermore, at the 6-month follow-up, only 23 patients in MTM group with poorly controlled blood glucose levels resulted in hospital admissions compared to 48 patients in non-MTM group, resulting in a 52.1% fewer hospital admissions (p< 0.001). CONCLUSIONS: The findings of this study implied that pharmacist-led medication therapy management might improve medication adherence and reduce number of hospitalizations in patients with type 2 diabetes mellitus. Hence, policies and guidelines should be in place in order for clinical pharmacists to fully engage in patient care and improve the medication therapy outcomes.
format Online
Article
Text
id pubmed-5597801
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-55978012017-09-22 The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study Erku, Daniel A. Ayele, Asnakew A. Mekuria, Abebe B. Belachew, Sewunet A. Hailemeskel, Bisrat Tegegn, Henok G. Pharm Pract (Granada) Original Research BACKGROUND: Poor adherence to antidiabetic medications leads to a higher rate of hospital admissions and adverse health outcomes in type 2 diabetes mellitus patients. OBJECTIVE: This study aims to evaluate whether a pharmacist-led medication therapy management, compared to the usual care, could enhance medication adherence and reduce hospital admission in patients with type 2 diabetes mellitus. METHODS: A prospective randomized controlled study was conducted in patients with type 2 diabetes mellitus from February 1 to July 30, 2016. Patients in the control group (n=65) received the usual care while patients in the intervention group (n=62) received a personalized pharmacotherapeutic care plan and diabetes education. The two groups were compared by repeated measure ANOVA at 3 and 6-months with medication adherence (using Morisky medication adherence scale) and number of hospital admissions as the main outcome variables. RESULTS: A total of 127 patients were included in the study. A marked and statistically significant increase in medication adherence from baseline to 3 and 6 months were noted in the intervention group (increased from 9.2% at baseline to 61% at 6 month) compared with the control group (increased from 13.2% at baseline (to 30.2% at 6 month; p-value<0.01). Furthermore, at the 6-month follow-up, only 23 patients in MTM group with poorly controlled blood glucose levels resulted in hospital admissions compared to 48 patients in non-MTM group, resulting in a 52.1% fewer hospital admissions (p< 0.001). CONCLUSIONS: The findings of this study implied that pharmacist-led medication therapy management might improve medication adherence and reduce number of hospitalizations in patients with type 2 diabetes mellitus. Hence, policies and guidelines should be in place in order for clinical pharmacists to fully engage in patient care and improve the medication therapy outcomes. Centro de Investigaciones y Publicaciones Farmaceuticas 2017 2017-08-26 /pmc/articles/PMC5597801/ /pubmed/28943985 http://dx.doi.org/10.18549/PharmPract.2017.03.1026 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Erku, Daniel A.
Ayele, Asnakew A.
Mekuria, Abebe B.
Belachew, Sewunet A.
Hailemeskel, Bisrat
Tegegn, Henok G.
The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
title The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
title_full The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
title_fullStr The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
title_full_unstemmed The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
title_short The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
title_sort impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597801/
https://www.ncbi.nlm.nih.gov/pubmed/28943985
http://dx.doi.org/10.18549/PharmPract.2017.03.1026
work_keys_str_mv AT erkudaniela theimpactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT ayeleasnakewa theimpactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT mekuriaabebeb theimpactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT belachewsewuneta theimpactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT hailemeskelbisrat theimpactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT tegegnhenokg theimpactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT erkudaniela impactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT ayeleasnakewa impactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT mekuriaabebeb impactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT belachewsewuneta impactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT hailemeskelbisrat impactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy
AT tegegnhenokg impactofpharmacistledmedicationtherapymanagementonmedicationadherenceinpatientswithtype2diabetesmellitusarandomizedcontrolledstudy